Showing results (241-250 of 261) with videos related to
Sort By:
Pageof 27
Blood|September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphomaGabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.The New England Journal of Medicine|July 14, 2016
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S Davids, Haesook T Kim, Pavan Bachireddy, et al.Nature|August 9, 2019
Observed controls on resilience of groundwater to climate variability in sub-Saharan AfricaMark O Cuthbert, Richard G Taylor, Guillaume Favreau, et al.JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.Blood|March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantationLivius Penter, Yi Zhang, Alexandra Savell, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyRanjana H Advani, Christopher R Kelsey, Philippe Armand, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 7, 2022
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyRichard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.Blood Advances|January 13, 2026
Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC StudyMarta Peña, Giulia Losi, Víctor Navarro, et al.Pageof 27